Skip to content

Drug interactions

Ifosfamide + Sparsentan

Severity: Minor

Ifosfamide and Sparsentan: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sparsentan is a weak CYP3A4 inducer, but CYP2C19 is only a minor route of ifosfamide metabolism. A clinically important change in ifosfamide exposure is not well documented. Possible CYP3A4 induction could modestly shift ifosfamide metabolism.

What this interaction means in plain words

Ifosfamide and Sparsentan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ifosfamide belongs to Oncology; Sparsentan belongs to Genitourinary.

Evidence level: Low

Why it happens

Weak enzyme induction by sparsentan may slightly alter ifosfamide metabolism; clinical significance is not established.

What to do

No routine adjustment is needed. Monitor for changes in ifosfamide response or toxicity.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ifosfamide and Sparsentan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ifosfamide with Sparsentan?

MediHelp rates the interaction as minor. Ifosfamide and Sparsentan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Sparsentan is a weak CYP3A4 inducer, but CYP2C19 is only a minor route of ifosfamide metabolism. A clinically important change in ifosfamide exposure is not well documented. Possible CYP3A4 induction could modestly shift ifosfamide metabolism.

How serious is the interaction between Ifosfamide and Sparsentan?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed. Monitor for changes in ifosfamide response or toxicity.

What other medicines interact with Ifosfamide?

MediHelp also lists interactions of Ifosfamide with, for example, Adenovirus types 4 and 7 live, Measles mumps and rubella vaccine, Measles mumps and rubella vaccine live. The full list is on the Ifosfamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in